RE.GA.IN. the Real-world Gastritis Initiative-updating the updates

Massimo Rugge*, Robert M. Genta, RE.GA.IN, Peter Malfertheiner, Mario Dinis-Ribeiro, Hashem El-Serag, David Y. Graham, Ernst J. Kuipers, Wai Keung Leung, Jin Young Park, Theodore Rokkas, Christian Schulz, Emad M. El-Omar

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

2 Citations (Scopus)
13 Downloads (Pure)


At the end of the last century, a far-sighted ' working party' held in Sydney, Australia addressed the clinicopathological issues related to gastric inflammatory diseases. A few years later, an international conference held in Houston, Texas, USA critically updated the seminal Sydney classification. In line with these initiatives, Kyoto Global Consensus Report, flanked by the Maastricht-Florence conferences, added new clinical evidence to the gastritis clinicopathological puzzle. The most relevant topics related to the gastric inflammatory diseases have been addressed by the Real-world Gastritis Initiative (RE.GA.IN.), from disease definitions to the clinical diagnosis and prognosis. This paper reports the conclusions of the RE.GA.IN. consensus process, which culminated in Venice in November 2022 after more than 8 months of intense global scientific deliberations. A forum of gastritis scholars from five continents participated in the multidisciplinary RE.GA.IN. consensus. After lively debates on the most controversial aspects of the gastritis spectrum, the RE.GA.IN. Faculty amalgamated complementary knowledge to distil patient-centred, evidence-based statements to assist health professionals in their real-world clinical practice. The sections of this report focus on: the epidemiology of gastritis; Helicobacter pylori as dominant aetiology of environmental gastritis and as the most important determinant of the gastric oncogenetic field; the evolving knowledge on gastric autoimmunity; the clinicopathological relevance of gastric microbiota; the new diagnostic horizons of endoscopy; and the clinical priority of histologically reporting gastritis in terms of staging. The ultimate goal of RE.GA.IN. was and remains the promotion of further improvement in the clinical management of patients with gastritis.

Original languageEnglish
Pages (from-to)407-441
Number of pages35
Issue number3
Early online date23 Feb 2024
Publication statusPublished - 2024

Bibliographical note

Publisher Copyright:
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.


Dive into the research topics of 'RE.GA.IN. the Real-world Gastritis Initiative-updating the updates'. Together they form a unique fingerprint.

Cite this